BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 8:39:00 PM | Browse: 1180 | Download: 1129
Publication Name World Journal of Gastroenterology
Manuscript ID 5409
Country Japan
Received
2013-09-06 11:20
Peer-Review Started
2013-09-06 18:23
To Make the First Decision
2013-10-14 21:16
Return for Revision
2013-10-15 14:44
Revised
2013-10-22 11:35
Second Decision
2013-11-18 21:01
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2013-11-19 12:17
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-12-05 10:57
Publish the Manuscript Online
2013-12-18 10:00
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Immunotherapy for colorectal cancer
Manuscript Source Invited Manuscript
All Author List Shigeo Koido, Toshifumi Ohkusa, Sadamu Homma, Yoshihisa Namiki, Kazuki Takakura, Keisuke Saito, Zensho Ito, Hiroko Kobayashi, Mikio Kajihara, Kan Uchiyama, Seiji Arihiro, Hiroshi Arakawa, Masato Okamoto, Jianlin Gong and Hisao Tajiri
Funding Agency and Grant Number
Funding Agency Grant Number
Grants in Aid for Scientific Research (C) from the Japanese Ministry of Education, Culture, Sports, Science and Technology
Corresponding Author Shigeo Koido, MD, Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, 163-1 Kashiwashita, Kashiwa-shi, Chiba 277-8567, Japan. shigeo_koido@jikei.ac.jp
Key Words Colorectal cancer; Cytotoxic T lymphocyte; Dendritic cell; Immunotherapy; Vaccine
Core Tip The prognosis for patients with recurrent or metastatic colorectal cancer (CRC) is extremely poor. Immunotherapy may be effective for treating CRC patients and/or preventing relapse. The immunotherapeutic approaches for CRC, including peptide vaccines, dendritic cell-based cancer vaccines, whole tumor cell vaccines, viral vector-based cancer vaccines, adoptive cell transfer therapy, antibody-based cancer immunotherapy, and cytokine therapy have been demonstrated. The blockade of multiple immune regulatory checkpoints combined with immunotherapy and/or conventional chemotherapy may be effective in treating patients with advanced CRC.
Publish Date 2013-12-18 10:00
Citation Koido S, Ohkusa T, Homma S, Namiki Y, Takakura K, Saito K, Ito Z, Kobayashi H, Kajihara M, Uchiyama K, Arihiro S, Arakawa H, Okamoto M, Gong J, Tajiri H. Immunotherapy for colorectal cancer. World J Gastroenterol 2013; 19(46): 8531-8542
URL http://www.wjgnet.com/1007-9327/full/v19/i46/8531.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i46.8531
Full Article (PDF) WJG-19-8531.pdf
Manuscript File 5409-Review.doc
Answering Reviewers 5409-Answering reviewers.pdf
Copyright License Agreement 5409-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 5409-Language certificate.pdf
Peer-review Report 5409-Peer review(s).pdf
Scientific Editor Work List 5409-Scientific editor work list.doc